Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas A Spencer

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Bioorganic & Medicinal Chemistry Letters|March 15, 2006
Preparation and biochemical evaluation of fluorenone-containing lipid analogsThomas A Spencer, Pingzhen Wang, Janeta V Popovici-Müller, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 8, 2004
CYP3A induction by liver x receptor ligands in primary cultured rat and mouse hepatocytes is mediated by the pregnane X receptorSarita D Shenoy, Thomas A Spencer, Nancy A Mercer-Haines, et al.
Journal of Lipid Research|June 4, 2004
Benzophenone-containing cholesterol surrogates: synthesis and biological evaluationThomas A Spencer, Pingzhen Wang, Dansu Li, et al.
Molecular Pharmacology|April 23, 2004
Induction of CYP3A by 2,3-oxidosqualene:lanosterol cyclase inhibitors is mediated by an endogenous squalene metabolite in primary cultured rat hepatocytesSarita D Shenoy, Thomas A Spencer, Nancy A Mercer-Haines, et al.
The Journal of Organic Chemistry|October 25, 2001
Zwitterionic Sulfobetaine Inhibitors of Squalene SynthaseThomas A. Spencer, Thomas J. Onofrey, Reginald O. Cann, et al.
Biochemistry|May 10, 2008
Structure and function of the sterol carrier protein-2 N-terminal presequenceGregory G Martin, Heather A Hostetler, Avery L McIntosh, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with ADElena Y Bryleva, Maximillian A Rogers, Catherine C Y Chang, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Bioorganic & Medicinal Chemistry Letters|March 15, 2006
Preparation and biochemical evaluation of fluorenone-containing lipid analogsThomas A Spencer, Pingzhen Wang, Janeta V Popovici-Müller, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 8, 2004
CYP3A induction by liver x receptor ligands in primary cultured rat and mouse hepatocytes is mediated by the pregnane X receptorSarita D Shenoy, Thomas A Spencer, Nancy A Mercer-Haines, et al.
Journal of Lipid Research|June 4, 2004
Benzophenone-containing cholesterol surrogates: synthesis and biological evaluationThomas A Spencer, Pingzhen Wang, Dansu Li, et al.
Molecular Pharmacology|April 23, 2004
Induction of CYP3A by 2,3-oxidosqualene:lanosterol cyclase inhibitors is mediated by an endogenous squalene metabolite in primary cultured rat hepatocytesSarita D Shenoy, Thomas A Spencer, Nancy A Mercer-Haines, et al.
The Journal of Organic Chemistry|October 25, 2001
Zwitterionic Sulfobetaine Inhibitors of Squalene SynthaseThomas A. Spencer, Thomas J. Onofrey, Reginald O. Cann, et al.
Biochemistry|May 10, 2008
Structure and function of the sterol carrier protein-2 N-terminal presequenceGregory G Martin, Heather A Hostetler, Avery L McIntosh, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with ADElena Y Bryleva, Maximillian A Rogers, Catherine C Y Chang, et al.
Pageof 2